Study of the NATURal History, Epidemiological, Clinical, Diagnostic and Therapeutic Aspects of CELiac Disease and Non-celiac Enteropathies
Launched by HOSPITAL MUTUA DE TERRASSA · Jul 8, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical study is focused on understanding celiac disease and other similar digestive conditions. Celiac disease is a long-term condition where eating gluten—a protein found in wheat, barley, and rye—causes damage to the small intestine in people who are genetically prone to it. This affects both children and adults and can lead to symptoms like stomach problems and poor nutrient absorption. Right now, the only treatment is to follow a strict gluten-free diet for life. The study aims to gather detailed information about people with celiac disease or related conditions, including their health history, genetics, immune system, and more, to help improve future research and care.
Anyone being tested or evaluated for celiac disease may be eligible to join the study, as long as they agree to participate by signing a consent form. If you take part, your health information and possibly biological samples (like blood) will be collected and stored in a special biobank to support ongoing research. The study is currently recruiting participants of all ages and genders. This research is important because it helps doctors learn more about celiac disease and related disorders, which could lead to better diagnosis and treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals under diagnostic evaluation for celiac disease
- Exclusion Criteria:
- • Failure to sign informed consent
About Hospital Mutua De Terrassa
Hospital Mutua de Terrassa is a leading healthcare institution located in Terrassa, Spain, dedicated to providing high-quality medical services and advancing clinical research. With a focus on innovation and patient-centered care, the hospital actively participates in clinical trials across various therapeutic areas, aiming to enhance treatment options and improve patient outcomes. Its multidisciplinary team of healthcare professionals collaborates closely with researchers and industry partners to ensure rigorous study protocols and ethical standards are upheld, fostering an environment of scientific excellence and community health advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Terrassa, Barcelona, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported